MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.
| Field | Value | Language |
| dc.contributor.author | Caillet, V | |
| dc.contributor.author | Keall, P | |
| dc.contributor.author | Colvill, E | |
| dc.contributor.author | Hardcastle, N | |
| dc.contributor.author | O'Brien, R | |
| dc.contributor.author | Szymura, K | |
| dc.contributor.author | Booth, JT | |
| dc.date.accessioned | 2018-08-07 | |
| dc.date.available | 2018-08-07 | |
| dc.date.issued | 2017-07-01 | |
| dc.identifier.citation | Radiother Oncol. 2017 Jul;124(1):18-24 | en |
| dc.identifier.uri | http://hdl.handle.net/2123/18638 | |
| dc.description.abstract | PURPOSE: Assess the dosimetric impact of multi-leaf collimator (MLC) tracking and mid-ventilation (midV) planning compared with the internal target volume (ITV)-based planning approach for lung Stereotactic Ablative Body Radiotherapy (SABR). METHOD: Ten lung SABR patients originally treated with an ITV-based plan were re-planned according to MLC tracking and midV planning schemes. All plans were delivered on a linac to a motion phantom in a simulated treatment with real lung motions. Delivered dose was reconstructed in patient planning scans. ITV-based, tracking and midV regimes were compared at the planning and delivered stages based on PTV volume and dose metrics for the GTV and OAR. RESULTS: MLC tracking and midV schemes yielded favourable outcomes compared with ITV-based plans. Average reduction in PTV volume was (MLC tracking/MidV) 33.9%/22%. GTV dose coverage performed better with MLC tracking than the other regimes. Reduction in dose to OAR were for the lung (mean lung dose, 0.8Gy/0.2Gy), oesophagus (D3cc, 1.9Gy/1.4Gy), great vessels (D10cc, 3.2Gy/1.3Gy), trachea (D4cc, 1.1Gy/0.9Gy), heart (D1cc, 2.0Gy/0.5Gy) and spinal cord (D0.03cc, 0.5Gy/-0.1Gy). CONCLUSION: MLC tracking showed reduction in PTV volume, superior GTV dose coverage and organ dose sparing than MidV and ITV-based strategies. | en |
| dc.publisher | Elsevier | en |
| dc.relation | NHMRC 1112096 | en |
| dc.rights | Other | |
| dc.subject | MLC tracking | en |
| dc.subject | Lung tumour | en |
| dc.title | MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk. | en |
| dc.type | Article | en |
| dc.subject.asrc | FoR::029903 - Medical Physics | en |
| dc.identifier.doi | 10.1016/j.radonc.2017.06.016 | |
| dc.type.pubtype | Preprint | en |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
Associated collections